Skip to main content
. 2016 Aug 18;11(8):e0161303. doi: 10.1371/journal.pone.0161303

Fig 3. Kaplan–Meier survival curve in intermediate-stage hepatocellular carcinoma patients receiving sorafenib.

Fig 3